1. New FDA reporting form

   Comment 18 January 2013 Pages: 2 - 2

2. Warning against intrathecal contrast agent use

   News item 18 January 2013 Pages: 2 - 2

3. FDA may set new requirements for toxicokinetic data

   Meeting report 18 January 2013 Pages: 3 - 3

4. Controversy over ovarian stimulation-cancer link

   News item 18 January 2013 Pages: 4 - 4

5. FDA data on flutamide

   Incidence study 18 January 2013 Pages: 4 - 4

6. In defence of β-agonists

   News item 18 January 2013 Pages: 4 - 4

7. Wellcome to pay pounds sterling 2.7M damages

   News item 18 January 2013 Pages: 4 - 4

8. Aciclovir

   Case report 18 January 2013 Pages: 5 - 5

9. Alcohol

   Case report 18 January 2013 Pages: 5 - 5

10. Amfebutamone overdose

    Case report 18 January 2013 Pages: 5 - 5

11. An association between hypertension and NSAID use

    Clinical study 18 January 2013 Pages: 5 - 5

12. Effects of steroids on behaviour confirmed

    Clinical study 18 January 2013 Pages: 5 - 5

13. Preoperative therapy with ACE inhibitors and calcium antagonists was not associated with low SVR

    Clinical study 18 January 2013 Pages: 5 - 5

14. Antineoplastics

    Case report 18 January 2013 Pages: 6 - 6

15. Antipsychotics

    Case report 18 January 2013 Pages: 6 - 6

16. Antipsychotics

    Clinical study 18 January 2013 Pages: 6 - 6

17. Antipsychotics

    Incidence study 18 January 2013 Pages: 6 - 6

18. Beclomethasone/fluticasone

    Clinical study 18 January 2013 Pages: 6 - 6

19. Bleomycin

    Case report 18 January 2013 Pages: 6 - 6

20. Botulinum toxin

    Case report 18 January 2013 Pages: 6 - 6

21. Bupivacaine

    Case reports 18 January 2013 Pages: 6 - 6

22. Busulfan

    Case report 18 January 2013 Pages: 7 - 7

23. Carbamazepine

    Case report 18 January 2013 Pages: 7 - 7

24. Carbamazepine interaction

    Case report 18 January 2013 Pages: 7 - 7

25. Ciprofloxacin

    Case report 18 January 2013 Pages: 7 - 7

26. Clomipramine

    Case report 18 January 2013 Pages: 7 - 7

27. Diclofenac

    Case reports 18 January 2013 Pages: 7 - 7

28. Digoxin interaction

    Case report 18 January 2013 Pages: 8 - 8

29. Ethambutol

    Case reports 18 January 2013 Pages: 8 - 8

30. Etretinate

    Case report 18 January 2013 Pages: 8 - 8

31. Fluorouracil

    Case report 18 January 2013 Pages: 8 - 8

32. Fluoxetine

    Case report 18 January 2013 Pages: 8 - 8

33. Foscarnet

    Case report 18 January 2013 Pages: 8 - 8

34. Glibenclamide

    Case report 18 January 2013 Pages: 9 - 9

35. Gliclazide interaction

    Case reports 18 January 2013 Pages: 9 - 9

36. Granulocyte colony-stimulating factor/granulocyte-macrophage colony-stimulating factor

    Case report 18 January 2013 Pages: 9 - 9

37. Growth hormone human

    Case report 18 January 2013 Pages: 9 - 9

38. H sub(2) antagonists interaction

    Clinical study 18 January 2013 Pages: 9 - 9

39. Heparin

    Case report 18 January 2013 Pages: 10 - 10

40. Iohexol

    Case report 18 January 2013 Pages: 10 - 10

41. Isoniazid

    Case reports 18 January 2013 Pages: 10 - 10

42. Isotretinoin

    Case report 18 January 2013 Pages: 10 - 10

43. Ketorolac

    Case report 18 January 2013 Pages: 10 - 10

44. Ketorolac

    Case reports 18 January 2013 Pages: 10 - 10

45. Lithium overdose

    Case report 18 January 2013 Pages: 10 - 10

46. Lovastatin

    Clinical study 18 January 2013 Pages: 11 - 11

47. Paclitaxel

    Case report 18 January 2013 Pages: 11 - 11

48. Paracetamol

    Case report 18 January 2013 Pages: 11 - 11

49. Prednisone

    Case report 18 January 2013 Pages: 11 - 11

50. Tacrolimus interaction

    Case report 18 January 2013 Pages: 11 - 11